sar
cov
pro
known
promis
target
develop
therapeut
agent
sever
acut
respiratori
syndrom
sar
quinolinon
compound
select
via
virtual
screen
synthet
test
enzymat
inhibit
vitro
compound
show
potent
inhibitori
activ
ic
toward
sar
cov
pro
work
seri
quinolinon
deriv
result
discoveri
potent
compound
inhibit
sar
cov
pro
ic
nmoll
structureact
relationship
also
discuss
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sar
cov
highli
infect
upper
respiratori
tract
diseas
due
high
mortal
rate
sar
quickli
becam
global
threat
although
year
later
first
discoveri
initi
outbreak
viru
stymi
reemerg
sar
quit
possibl
develop
new
antisar
drug
particularli
import
sar
cov
positivesens
singlestrand
rna
viru
genom
compris
nucleotid
nucleotid
belong
replicas
gene
encod
two
overlap
polyprotein
kda
kda
sar
cov
pro
kda
cystein
proteas
releas
function
polypeptid
without
polypeptid
viral
replic
transcript
disabl
integr
role
sar
cov
pro
sar
cov
lifecycl
ideal
target
drug
discoveri
previous
larg
number
sar
cov
pro
inhibitor
report
scaffold
divers
yang
et
al
develop
potent
sar
cov
proteas
inhibitor
nmoll
figur
sydn
et
al
synthet
seri
glutam
acid
glutamin
peptid
possess
trifluoromethyl
keton
group
effect
inhibitori
activ
zhou
et
al
report
ic
figur
analogu
highli
potent
sar
cov
pro
inhibitor
identifi
novel
sar
cov
pro
inhibitor
among
databas
contain
compound
virtual
screen
compound
figur
select
synthet
test
sar
cov
pro
vitro
show
potent
inhibitori
activ
ic
toward
sar
cov
pro
compound
synthes
test
sar
cov
pro
vitro
biolog
evalu
result
titl
compound
list
tabl
shown
tabl
replac
thiophen
moieti
compound
benzen
ring
compound
lead
decreas
inhibitori
activ
especi
benzen
ring
substitut
worth
higher
potenc
compound
nitrogen
oxygen
sulfur
atom
color
blue
red
orang
respect
hydrogen
bond
display
blue
dash
line
figur
show
dock
model
compound
conclud
compound
bind
competit
strongli
activ
site
quinolinon
portion
recogn
pocket
moreov
thiophen
moieti
extend
site
hydrophob
interact
pocket
quit
larg
may
explain
compound
long
carbon
chain
aromat
ring
ester
carbonyl
show
lower
potenc
compound
unlik
compound
methyl
nh
quinolinon
bring
differ
bind
interact
thiophen
moieti
compound
occupi
pocket
methyl
group
fill
crack
pocket
close
pocket
much
nearer
surfac
protein
pocket
new
bind
model
make
compound
bind
tightli
compound
protein
may
partli
explain
compound
show
potent
inhibitori
effect
compar
compound
molecular
insight
two
differ
bind
mode
compound
shown
figur
oxygen
quinolinon
moieti
compound
make
hbond
nh
nh
quinolinon
form
hbond
glu
ester
carbonyl
oxygen
form
hydrogen
bond
nh
gli
compound
hydro
gen
bond
amid
carbonyl
oxygen
nh
also
conserv
well
hydrogen
bond
glu
methyl
ester
carbonyl
oxygen
compound
make
hydrogen
bond
activ
site
residu
cy
differ
two
bind
mode
activ
site
sar
cov
pro
contain
catalyt
dyad
constitut
cy
function
common
nucleophil
proteolyt
process
mean
although
methyl
disturb
hydrogen
bond
nh
quinolinon
distanc
ester
carbonyl
oxygen
sh
group
cy
nh
group
might
chang
favor
result
dramat
inhibitori
potenc
addit
carbonyl
compound
may
potenti
react
cy
residu
suppos
remain
studi
conclus
twentythre
quinolinon
compound
synthes
test
vitro
inhibitor
sar
cov
pro
compound
select
via
virtual
screen
prove
potent
inhibitori
activ
ic
follow
optim
ester
deriv
result
discoveri
compound
power
potenc
ic
nmoll
present
work
demonstr
ester
analog
could
use
new
lead
futur
antisar
drug
discoveri
structur
optim
vivo
activ
quinolinon
compound
well
way
unless
otherwis
note
chemic
solvent
commerci
avail
treat
standard
method
use
melt
point
determin
use
digit
melt
point
apparatu
uncorrect
shanghai
sanpont
plate
use
analyt
tlc
h
c
nmr
spectra
record
mhz
bruker
avanc
dpx
spectromet
use
dmso
solvent
c
nmr
spectra
record
protondecoupl
chemic
shift
h
c
spectra
quot
ppm
downfield
tm
coupl
constant
refer
j
valu
hertz
esi
mass
spectra
acquir
use
bruker
esquirelctm
esi
ion
trap
spectromet
ftir
spectra
record
room
temperatur
region
cm
perkinelm
spectrum
ftir
spectromet
use
kbr
pellet
element
analys
carbon
hydrgen
nitrogen
obtain
elementar
vario
micro
cube
element
analys
suspens
compound
prepar
accord
gener
procedur
use
chlorid
obtain
white
solid
yield
mp
compound
prepar
accord
gener
procedur
use
chlorid
obtain
white
solid
yield
mp
compound
prepar
accord
gener
procedur
use
chlorid
obtain
white
solid
yield
sequenc
sarscov
pro
clone
vector
transform
e
coli
cell
recombin
protein
gsttag
purifi
gstglutathion
affin
chromatographi
ion
exchang
column
eventu
purifi
protein
high
puriti
judg
sdspage
analysi
concentr
buffer
mmoll
trishcl
ph
mmoll
edta
substrat
synthes
shanghai
biolog
engin
compani
dissolv
dmso
mmoll
liquid
storag
use
sarscov
pro
inhibit
assay
conduct
via
fluoresc
reson
energi
transfer
fret
natur
substrat
amino
acid
sequenc
avlq
sgfrkk
sarscov
pro
end
mca
fluoresc
group
dnp
fluoresc
quench
group
system
screen
follow
tabl
settl
concentr
protein
compound
substrat
preheat
oscil
excitationemiss
light
nm
test
carri
everi
time
draw
curv
maximum
valu
neg
control
curv
slope
v
largest
compound
curv
slope
v
inhibit
ratio
defin
v
ic
valu
calcul
follow
equat
crystal
structur
sarscov
pro
code
obtain
protein
data
bank
complex
bound
inhibitor
use
dock
studi
dock
studi
carri
discoveri
studio
prepar
protein
dock
water
molecul
inhibitor
remov
hydrogen
atom
ad
use
prepar
protein
structur
modul
protein
